Date: 12/15/2025 1. Introduction Tilray Brands, Inc. (NASDAQ: TLRY) is a diversified global lifestyle consumer packaged goods (CPG) company operating at the dynamic intersection of the cannabis, alcoholic beverage, and wellness industries. Headquartered in New York City, Tilray boasts a significant operational footprint across Canada, the United States, Europe, Australia, New Zealand, and Latin America, [...]
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
fell 5.2% in the afternoon session after the stock gave back some of its recent gains, which were fueled by reports that the U.S. administration was considering reclassifying marijuana.
Tilray stock soared today after President Donald Trump signalled reclassification of cannabis as a Schedule III drug in the near-term. Here’s what that means for TLRY shares heading into 2026.
Monday’s tape felt like markets were pacing in the hallway before a doctor’s appointment: slightly red, slightly tense, and absolutely obsessed with the next data print. Oracle kept sliding on “more AI capex” anxiety, while Tesla ripped higher on Cathie Wood’s megaphone? plus a handful of single-stock soap operas stole the show.
As the trading day commenced on December 15, 2025, Wall Street opened with a complex tapestry of movements across its major indices. While the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite displayed a nuanced performance, market participants keenly observed several individual stocks making significant waves. The day's
A late-week mood swing around AI spending slammed tech and dragged the major indexes off record highs. Broadcom’s guidance nuance got punished, Oracle’s OpenAI data-center noise didn’t help, and suddenly “AI” felt less like a love story and more like a capex therapy session.
The financial markets experienced a week of significant upward momentum for several key players, culminating on December 13, 2025, as investors eagerly anticipated and then reacted to a confirmed Federal Reserve interest rate cut. This monetary policy shift, coupled with robust merger and acquisition (M&A) activity and strong corporate
Washington D.C. – December 12, 2025 – In a move sending seismic waves through the financial markets, President Donald Trump is reportedly poised to enact a landmark reclassification of marijuana, shifting it from a Schedule I to a Schedule III controlled substance under federal law. The news, which broke late on
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
jumped 40.8% in the afternoon session after reports suggested the Trump administration planned to ease federal restrictions on marijuana by reclassifying it as a less dangerous substance.
